Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Porro

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 1999
Prediction of the systemic exposure to oral 9-amino-20(S)-camptothecin using single-sample analysisA Sparreboom, M J de Jonge, C J Punt, et al.
Cancer Chemotherapy and Pharmacology|September 26, 2014
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic functionMarije Slingerland, Dagmar Hess, Sally Clive, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2014
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal functionSunil Sharma, Petronella O Witteveen, Martijn P Lolkema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacokinetic study of a daily times 5 short intravenous infusion schedule of 9-aminocamptothecin in a colloidal dispersion formulation in patients with advanced solid tumorsV M Herben, R van Gijn, J H Schellens, et al.
British Journal of Cancer|June 10, 2004
Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)D Bissett, J Cassidy, J S de Bono, et al.
Biomedizinische Technik. Biomedical Engineering|September 18, 2013
Continuous Blood Glucose Monitoring (Cgm) System Based on Intravenous Microdialysis and Glucose SensingH Greiner, R Schaller-Ammann, A Huber, et al.
Leukemia|July 20, 2007
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cellsJ Golay, L Cuppini, F Leoni, et al.
Obstetrical & Gynecological Survey|September 1, 1980
Plasma levels and clinical effects of antiepileptic drugs in pregnant epileptic patients and their newbornsL Bossi, B M Assael, G Avanzini, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 1999
Prediction of the systemic exposure to oral 9-amino-20(S)-camptothecin using single-sample analysisA Sparreboom, M J de Jonge, C J Punt, et al.
Cancer Chemotherapy and Pharmacology|September 26, 2014
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic functionMarije Slingerland, Dagmar Hess, Sally Clive, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2014
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal functionSunil Sharma, Petronella O Witteveen, Martijn P Lolkema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacokinetic study of a daily times 5 short intravenous infusion schedule of 9-aminocamptothecin in a colloidal dispersion formulation in patients with advanced solid tumorsV M Herben, R van Gijn, J H Schellens, et al.
British Journal of Cancer|June 10, 2004
Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)D Bissett, J Cassidy, J S de Bono, et al.
Biomedizinische Technik. Biomedical Engineering|September 18, 2013
Continuous Blood Glucose Monitoring (Cgm) System Based on Intravenous Microdialysis and Glucose SensingH Greiner, R Schaller-Ammann, A Huber, et al.
Leukemia|July 20, 2007
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cellsJ Golay, L Cuppini, F Leoni, et al.
Obstetrical & Gynecological Survey|September 1, 1980
Plasma levels and clinical effects of antiepileptic drugs in pregnant epileptic patients and their newbornsL Bossi, B M Assael, G Avanzini, et al.
Pageof 6